Dr. Lee is a board-certified retina surgeon and clinician-scientist with extensive experience in managing complex vitreoretinal diseases, including age-related macular degeneration (AMD), inherited retinal diseases (IRD), and diabetic retinopathy (DR). As an already fully trained vitreoretinal surgeon from South Korea, she completed her training again at top, nationally-ranked ophthalmology programs in the United States, including the Johns Hopkins University, University of Southern California, and University of Iowa for postdoctoral fellowship, ophthalmology residency, and vitreoretinal surgery fellowship training respectively.
Expanding upon Dr. Lee's expertise in retinal drug discovery, pre-clinical experimental design, and retinal cell biology and biochemistry, Dr. Lee's research program, funded by the National Eye Institute (NEI), currently focuses on studying the role of extracellular vesicles (EVs), especially small EV (freuqnetly called as exosomes), in retinal diseases and developing innovative EV-based intraocular therapies. EV-based intraocular therapy holds a promise for next generation drug delivery, gene therapy and stem cell therapy for retina diseases with limited or no treatment available.

For more information on Dr. Lee’s work, visit LeeRetinaLab.com